Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ACC 2021
Pharma
Regeneron's Evkeeza aces triglyceride control in some patients
New data presented at ACC Sunday could support Regeneron’s case for a bigger Evkeeza approval—provided it can test and target the right patients.
Eric Sagonowsky
May 16, 2021 9:33am
Farxiga may not help COVID patients, but it’s safe enough: study
May 16, 2021 8:00am
J&J's Xarelto charts long-term win in post-surgery PAD patients
May 16, 2021 8:00am
Novartis sifts for nuggets in Entresto's post-heart attack loss
May 15, 2021 9:00am
